FCB Pharmicell's stem cell storage bank provides the most suitable condition for production of cell therapeutics.
The core objective of stem cell storage is to store in the most suitable condition so that cells may be used for treatment upon client request. A group of researchers who were the first to succeed in autologous transplantation with only the use of PBSC (Peripheral Blood Stem Cell) in 1995 and possess excellent technology that can manufacture stored stem cell into therapeutics, are directly in-charge of the operations. Through clinical trials that are currently under process, we have obtained a safe and long-term cell freezing and storage technology as well as culturing technology that defrosts the cell and maintains it in a usable form.
FCB Pharmicell's stem cell storage bank brand name is TwelveTM. TwelveTM is a diverse business that stores an infant's cord blood to an adult's adult stem cell to actualize the common dream of prolonging life.
FCB-Pharmicell Co.,Ltd. 920 Sicox Tower 513-14, Sangdaewon1-dong, Jungwon-gu, Seongnam-si, Gyeonggi-do, Korea ¤ýT.82.31.777.9340 ¤ýF. 82.31.777.9343
COPYRIGHT(C) 2007 FCB-PHAMICELL CO.,Ltd. ALL RIGHTS RESERVED.
